Ask any one who is really in the M&A space and find out.
From Germany to Dubai, the money is lined up and hoping for a shot to sit down and talk to Lief
SOUTH SAN FRANCISCO,Calif. (AP) -- Onyx Pharmaceuticals Inc. on Sunday confirmed that it received an unsolicited takeover bid from Amgen Inc. for $120 per share. But the drug developer says it rejected the offer, because it "significantly undervalued" the company.